list of glp-1 drugs for weight loss Unlocking The Power What's the skinny on weight-loss

Description

What are the most common side effects of GLP-1 medications

The participants in the studies were 43,522 with DPP-4 inhibitors, 60,080 with GLP-1RA, and 77,541 with SGLT-2 inhibitors, for a total number of 181,143 participants

Safety and Side Effects Common Side Effects While GLP-1 agonists offer significant benefits for managing type 2 diabetes and promoting weight loss, they are not without potential side effects

Novo Nordisk maintains first-to-market advantage with semaglutide across diabetes (Ozempic), obesity (Wegovy), and oral (Rybelsus) formulations, with the oral version launching in January 2026 following December 2025 FDA approval [3]

Diabetes Obes Metab 24(8):15531564 Wharton S et al (2021) Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data